Pregled bibliografske jedinice broj: 31143
Immunologic detection of minimal residual disease (MRD)
Immunologic detection of minimal residual disease (MRD) // Fourth seminar New Trends in the Treatment of Acute Leukaemia / Mrsić, Mirando ; Labar, Boris (ur.).
Zagreb: University Hospital Rebro Zagreb and European School of Oncology, 1996. str. 33-33 (pozvano predavanje, domaća recenzija, cjeloviti rad (in extenso), pregledni)
CROSBI ID: 31143 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Immunologic detection of minimal residual disease (MRD)
Autori
Batinić, Drago
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, cjeloviti rad (in extenso), pregledni
Izvornik
Fourth seminar New Trends in the Treatment of Acute Leukaemia
/ Mrsić, Mirando ; Labar, Boris - Zagreb : University Hospital Rebro Zagreb and European School of Oncology, 1996, 33-33
Skup
Fourth seminar New Trends in the Treatment of Acute Leukaemia
Mjesto i datum
Brijuni, Hrvatska, 14.09.1996. - 17.09.1996
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
Minimal residual disease; acute leukemia; flow cytometry
Sažetak
During the last decade there has been a continuous effort to develop more sensitive technique for the detection and monitoring of minimal residual disease (MRD) in patients treated for acute leukemia (AL). This approach may help clinicians to redefine the criteria used to classify remission and to evaluate the efficacy os specific threapeutic strategies both in vivo and ex vivo (purging technique), with the ultimate goal to tailor therapy to needs of each patients. Immunologic detection of MRD has been considerably improved by advances in multiparameter flow cytometric analysis (MFC), a technique that permits sensitive detection of specific cell types in a heterogenous cell population.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
